Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cyberonics Inc Raises FY 2013 Guidance


Friday, 22 Feb 2013 07:00am EST 

Cyberonics Inc announced that based on the financial and operating results through the third quarter of 2013, the implementation of the medical device tax and the reinstatement of the research and development tax credit, the Company has adjusted the guidance for fiscal 2013 as; net sales guidance in the range from $248 million to $250 million (compared to previous guidance range of $246 million to $249 million, income from operations (now inclusive of the medical device tax) in the range from $75 million to $77 million, compared to previous guidance of $73 million to $75 million exclusive of the medical device tax), Adjusted net income in the range from $46 million to $48 million (compared to previous guidance of $43 million to $45 million) and adjusted diluted earnings per share in the range from $1.66 to $1.72 (compared to previous guidance of $1.56 to $1.62). Guidance for adjusted net income and adjusted diluted earnings per share excludes a loss of $2.5 million (net of tax), or $0.09 cents per share, for an investment write-down in the first quarter, and a gain on warrant liability of $1.3 million, or $0.05 cents per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $248 million, net income of $45 million, EBIT of $74 million and EPS of $1.60 for fiscal 2013. 

Company Quote

58.51
-0.41 -0.70%
25 Jul 2014